Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Bevacizumab Injection

Approval Number

国药准字S20240051

Company华兰基因工程有限公司

Registration Date

November 15, 2024

Drug Information

Generic Name

贝伐珠单抗注射液

Trade Name

安贝优

Dosage Form

注射剂

Strength

100mg（4mL）/瓶

Drug Type

生物制品

Registration Date

November 15, 2024

Company Information

Applicant Company

Company Name华兰基因工程有限公司

Company Address

新乡市平原示范区黄河路甲1-1号

Manufacturing Company

Company Name华兰基因工程有限公司

Company Address

新乡市平原新区黄河大道中段

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

贝伐珠单抗注射液 - NMPA 批准文号 | MedPath